- Home
- IGC vs MYO Comparison
IGC vs MYO Comparison
Compare IGC & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- MYO
- Stock Information
- Founded
- IGC 2005
- MYO 2004
- Country
- IGC United States
- MYO United States
- Employees
- IGC N/A
- MYO N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- MYO Industrial Specialties
- Sector
- IGC Health Care
- MYO Health Care
- Exchange
- IGC Nasdaq
- MYO Nasdaq
- Market Cap
- IGC 33.8M
- MYO 36.5M
- IPO Year
- IGC N/A
- MYO 2017
- Fundamental
- Price
- IGC $0.32
- MYO $0.84
- Analyst Decision
- IGC Strong Buy
- MYO Strong Buy
- Analyst Count
- IGC 2
- MYO 3
- Target Price
- IGC $4.00
- MYO $7.67
- AVG Volume (30 Days)
- IGC 703.5K
- MYO 890.9K
- Earning Date
- IGC 11-17-2025
- MYO 11-10-2025
- Dividend Yield
- IGC N/A
- MYO N/A
- EPS Growth
- IGC N/A
- MYO N/A
- EPS
- IGC N/A
- MYO N/A
- Revenue
- IGC $1,106,000.00
- MYO $41,643,203.00
- Revenue This Year
- IGC $3.54
- MYO $24.69
- Revenue Next Year
- IGC $15.12
- MYO $20.91
- P/E Ratio
- IGC N/A
- MYO N/A
- Revenue Growth
- IGC N/A
- MYO 65.00
- 52 Week Low
- IGC $0.25
- MYO $0.71
- 52 Week High
- IGC $0.50
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- IGC 27.94
- MYO 46.54
- Support Level
- IGC $0.31
- MYO $0.71
- Resistance Level
- IGC $0.33
- MYO $0.88
- Average True Range (ATR)
- IGC 0.02
- MYO 0.07
- MACD
- IGC -0.01
- MYO 0.01
- Stochastic Oscillator
- IGC 8.50
- MYO 48.83
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).